Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
Coronavirus (COVID-19) and CMT
COVID-19 VACCINE AND CMT Q&A* [This page last updated on 5/25/2021.] What are the side effects of the COVID vaccine? Will they affect my CMT? The known side effects of…
A Guide to Physical and Occupational Therapy for CMT
…CMT clinicians, CMTA sponsored a workshop and brought together physical and occupational therapists from CMTA’s Centers of Excellence to collaborate on a guide to help you and your therapists better…
Encouraging News in CMT Research from CMTA-STAR Alliance Partner Alesta Therapeutics
…are encouraging for CMT. CMTA shares this exciting update from our CMTA-STAR Alliance Partner as part of our mission to empower the CMT community with the latest research breakthroughs, driving…
Frequently Asked Questions: Ionis/CMTA 1A Research Announcement
…subtypes of CMT? The ASOs developed for this publication are specifically designed to apply to CMT1A, since they target the duplicated PMP22 gene that causes CMT1A. Therefore, they would not…
CMTA Awards $225,483 for Study On Using ASOs to Treat CMT2E
…is the largest philanthropic funder of CMT research worldwide. The CMTA’s Strategy to Accelerate Research (STAR) brings the best CMT researchers, clinicians, and experts in therapy development together with patients,…
CMTA Appoints Biotech Industry Veteran Suzanne Bruhn, PhD as New CEO
…join the CMTA, the largest philanthropic funder of CMT research in the world, and the provider of the most CMT patient services in the world. I have spent my career…
Let’s Beat CMT – 2024 CMT Awareness Month
…media using #LetsBeatCMT to educate the world about CMT’s impact and share advice to others living with CMT. Watch the video below. CMT impacts everyone differently and it is time…
Advancements in CMT1A and CMT1B Research Highlight CMTA’s Impact
…the Health Sciences (USU). The paper, published in Cellular and Molecular Life Sciences, reports encouraging advancements in the search for treatments for CMT1A and CMT1B. Building on his previous CMTA-funded…
CMTA’s Strategic Investment Advances Research for CMT1A and CMT1B
The Charcot-Marie-Tooth Association (CMTA) continues its mission to accelerate research that impacts the lives of those living with Charcot-Marie-Tooth disease (CMT). Building on previous successes, CMTA announced earlier this year…
Development of Advanced Research Diagnostic Capabilities for the CMT Community
…CMT subtype, have already been identified, more than 50% of patients do not receive a genetic diagnosis today. We call this the diagnostic gap in CMT. We have set out…